Sustained Immunogenic and Clinical Effects of Low-Dose Interleukin-2 Therapy with an Intermittent Maintenance Method for Refractory Chronic Graft-Versus-Host Disease: Results of Phase1/2a LDIL2-01 Study

被引：0
|
作者：
Meguri, Yusuke [1 ]
Ohashi, Kazuteru [2 ]
Inamoto, Yoshihiro [3 ]
Iyama, Satoshi [4 ]
Ohwada, Chikako [5 ]
Murata, Makoto [6 ]
Satake, Atsushi [7 ]
Mori, Yasuo [8 ]
Nakase, Koichi [9 ]
Yoshida, Chikamasa [10 ]
Doki, Noriko [2 ]
Najima, Yuho [2 ]
Nishida, Tetsuya [6 ]
Maeda, Yoshinobu [1 ]
Matsuoka, Ken-ichi [1 ]
机构：
[1] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
[2] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[3] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[4] Sapporo Med Univ Hosp, Dept Hematol, Sapporo, Hokkaido, Japan
[5] Chiba Univ Hosp, Dept Hematol, Chiba, Japan
[6] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[7] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan
[8] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Japan
[9] Ehime Prefectural Cent Hosp, Div Hematol, Matsuyama, Ehime, Japan
[10] Natl Hosp Org Minami Okayama Med Ctr, Div Hematol, Okayama, Japan
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
256
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [1] Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease
    Donato, Veronica
    Kim, Haesook T.
    Stowe, Peter
    Reynolds, Carol G.
    Ritz, Jerome
    Koreth, John
    Whangbo, Jennifer S.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
    Koreth, John
    Kim, Haesook T.
    Jones, Kyle T.
    Lange, Paulina B.
    Reynolds, Carol G.
    Chammas, Marie J.
    Dusenbury, Katherine
    Whangbo, Jennifer
    Nikiforow, Sarah
    Alyea, Edwin P., III
    Armand, Philippe
    Cutler, Corey S.
    Ho, Vincent T.
    Chen, Yi-Bin
    Avigan, David
    Blazar, Bruce R.
    Antin, Joseph H.
    Ritz, Jerome
    Soiffer, Robert J.
    BLOOD, 2016, 128 (01) : 130 - 137
  • [3] Low Dose of Interleukin-2 Therapy Could Prevent Chronic Graft-Versus-Host Disease: A Randomized Study
    Zhao, Xiangyu
    Zhao, Xiaosu
    Wang, Yutong
    Qian, Xin
    Chang, Yingjun
    Xu, Lanping
    Zhang, Xiaohui
    Chen Yuhong
    Wang, Yu
    Han, Wei
    Chen, Huan
    Yan, Chenhua
    Wang, Fengrong
    Wang Jingzhi
    Chen, Yao
    Sun, Yuqian
    Liu, Kaiyan
    Huang, Xiaojun
    BLOOD, 2014, 124 (21)
  • [4] Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children
    Whangbo, Jennifer S.
    Kim, Haesook T.
    Mirkovic, Nikola
    Leonard, Lauren
    Poryanda, Samuel
    Silverstein, Sophie
    Kim, Soomin
    Reynolds, Carol G.
    Rai, Sharmila C.
    Verrill, Kelly
    Lee, Michelle A.
    Margossian, Steven
    Duncan, Christine
    Lehmann, Leslie
    Huang, Jennifer
    Nikiforow, Sarah
    Alyea, Edwin P., III
    Armand, Philippe
    Cutler, Corey S.
    Ho, Vincent T.
    Blazar, Bruce R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    Koreth, John
    BLOOD ADVANCES, 2019, 3 (17) : 2550 - 2561
  • [5] Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
    Kim, Haesook T.
    Koreth, John
    Whangbo, Jennifer
    Nikiforow, Sarah
    Reynolds, Carol G.
    Stowe, Peter
    Ho, Vincent T.
    Cutler, Corey
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    BLOOD ADVANCES, 2022, 6 (15) : 4392 - 4402
  • [6] Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
    Matsuoka, Ken-ichi
    Koreth, John
    Kim, Haesook T.
    Bascug, Gregory
    McDonough, Sean
    Kawano, Yutaka
    Murase, Kazuyuki
    Cutler, Corey
    Ho, Vincent T.
    Alyea, Edwin P.
    Armand, Philippe
    Blazar, Bruce R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (179)
  • [7] Low-dose interleukin-2 for the treatment of glucocorticoid-refractory acute graft-versus-host disease: a single center experience
    Brandt, A.
    Voelkl, S.
    Vasova, I
    Winkler, J.
    Mackensen, A.
    Roesler, W.
    Spoerl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 53 - 53
  • [8] Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host Disease
    Asano, Takeru
    Matsuoka, Ken-Ichi
    Iyama, Satoshi
    Ohashi, Kazuteru
    Inamoto, Yoshihiro
    Ohwada, Chikako
    Murata, Makoto
    Satake, Atsushi
    Yoshida, Chikamasa
    Nakase, Koichi
    Mori, Yasuo
    Tanimoto, Mitsune
    ACTA MEDICA OKAYAMA, 2016, 70 (05) : 429 - 433
  • [9] A review of low dose interleukin-2 therapy in management of chronic graft-versus-host-disease
    Salhotra, Amandeep
    Falk, Leah
    Park, Gabriel
    Sandhu, Karamjeet
    Ali, Haris
    Modi, Badri
    Hui, Susanta
    Nakamura, Ryotaro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (02) : 169 - 184
  • [10] Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease
    Whangbo, Jennifer S.
    Kim, Haesook T.
    Nikiforow, Sarah
    Koreth, John
    Alho, Ana C.
    Falahee, Bryn
    Kim, Soomin
    Dusenbury, Katharine
    Fields, Marie J.
    Reynolds, Carol G.
    Alyea, Edwin P., III
    Armand, Philippe
    Cutler, Corey S.
    Ho, Vincent T.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    BLOOD ADVANCES, 2019, 3 (07) : 984 - 994
12345